Eli Lilly Reports $7.02 EPS Beat, Raises Dividend to $1.73 and Issues FY2025 Guidance
LLY beat Q3 estimates with $7.02 EPS on $17.60B revenue (up 53.9%), exceeding consensus by $0.60 and $1.51B, and issued FY2025 EPS guidance of 23.00–23.70. The company raised its quarterly dividend 15.3% to $1.73 and holds a consensus “Buy” rating with a $1,174.61 target price.
1. Institutional Buying Builds Momentum
BAM Wealth Management LLC initiated a position in Eli Lilly and Company during the third quarter, acquiring 1,424 shares valued at approximately $1.09 million. This new stake represents 0.8% of BAM’s total portfolio and ranks Lilly as their 25th largest holding. Other recent institutional moves include Sumitomo Mitsui Financial Group’s $27,000 second-quarter purchase, Evolution Wealth Management’s $29,000 stake, and Steph & Co.’s 290% increase to 39 shares. Financial Gravity Companies entered with a $31,000 position, while Bare Financial Services expanded its holding by 263.6% to 40 shares. Collectively, hedge funds and institutions now own 82.53% of the company’s outstanding shares, underscoring broad confidence among professional investors.
2. Analysts Affirm Buy Ratings with Elevated Targets
Research firms remain overwhelmingly positive on Lilly, with four analysts assigning a Strong Buy, eighteen a Buy, and four a Hold. Bank of America, while trimming its target from 1,286 to 1,268, maintained its Buy rating. Goldman Sachs raised its target from 951 to 1,145, also with a Buy. CICC Research lifted its price objective from 801 to 1,060 and kept a Neutral rating, and Berenberg Bank raised its target from 830 to 950 while retaining a Hold. UBS Group initiated coverage with a Buy rating and a 1,250 target. The consensus target across analysts stands at 1,174.61, reflecting strong upside expectations.
3. Robust Earnings Beat and Upward Guidance
In the quarter ending October 30, the company delivered earnings per share of 7.02, outperforming the consensus by 0.60, on revenues of 17.60 billion versus estimates of 16.09 billion. Year-over-year, revenue grew 53.9% and EPS jumped from 1.18 to 7.02. Net margin reached 30.99% and return on equity was 109.52%. Management set full-year guidance of 23.00–23.70 EPS, with analysts forecasting 23.48. Balance sheet metrics remain solid, with a current ratio of 1.55, quick ratio of 1.24 and debt-to-equity of 1.71, supporting continued investment in R&D and pipeline expansion.
4. Dividend Raised to Reflect Cash Flow Strength
The board approved a quarterly dividend increase to 1.73 per share, up from 1.50, payable March 10 to holders of record as of February 13. On an annualized basis, this boost translates to 6.92 per share and a yield of approximately 0.6%. The dividend payout ratio stands at 29.35%, leaving ample room for future hikes given robust free cash flow generation and the company’s commitment to returning capital to shareholders.